(Q44943405)

English

Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: a nationwide Taiwan database analysis of long-term outcome predictors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: a nationwide Taiwan database analysis of long-term outcome predictors (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Hon-Yi Shi

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Shen-Nien Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Shih Chin Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Shih-Chang Chuang

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Chun-Min Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

King-Teh Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

30 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Journal of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

109

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

487-493

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Hepatocellular carcinoma: current management and perspectives for the future

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

Is resection equivalent to transplantation for early cirrhotic patients with hepatocellular carcinoma? A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

Invited commentary: propensity scores

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

Estimating causal effects from large data sets using propensity scores

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

Physician performance information and consumer choice: a survey of subjects with the freedom to choose between doctors

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

Is Preoperative Transarterial Chemoembolization Needed for a Resectable Hepatocellular Carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23521

21 January 2018

Identifiers

10.1002/JSO.23521

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44943405&oldid=2059091225"